Catalonia urges EU to speed up vaccine evaluations, eyes Russian shots

While infection rates have retreated from January's peak, 40% of all intensive care beds are still occupied by COVID-19 patients.
In Catalonia, in Spain's northeast, the figure is close to 45%. In a phone interview, Pere Aragones said this was unsustainable in the medium term.

Related news

Pandemic compensation claims by Mallorcan companies rejected by Spain's Supreme Court

More related news

"We urge European authorities to accelerate the evaluation processes of vaccines, for instance the Sputnik, which could have a major positive impact," he said.

Peer-reviewed late-stage trial results published in the international medical journal The Lancet this month and endorsed by outside scientists showed the Russian vaccine to be almost 92% effective in preventing COVID-19 symptoms.
Catalonia accounts for almost 10,000 of the more than 64,000 people who have succumbed to the virus in Spain.

It has so far administered over 357,000 doses of the three available vaccines, but Aragones said it had the capacity to administer around 150,000 a day.